Alexandre Detappe | Nanomedicine Award | Young Scientist Award

Published on by Global Academic Awards

Prof. Alexandre Detappe | Nanomedicine Award | Young Scientist Award

Prof. Alexandre Detappe, ICANS, France

Prof. Alexandre Detappe is a distinguished biophysicist and a leading figure in cancer research. Holding a PhD from the University of Lyon, France, he has contributed significantly to understanding and combating diseases like multiple myeloma and HER2+ breast cancer. Currently a Professor at Strasbourg Medical School, his research focuses on developing innovative drug delivery systems and small molecules to enhance immune responses against cancer. With extensive academic and institutional appointments, he co-founded several biotech companies, reflecting his commitment to translating research into practical solutions. Detappe’s multifaceted expertise and leadership in translational medicine make him a pivotal figure in advancing cancer therapeutics. 🧬🩺🔬

 

PUBLICATION PROFILE

Orcid

EDUCATION

Dr. Alexandre Detappe is a distinguished scholar in biophysics, with a rich educational background spanning renowned institutions in France. He earned his Bachelor’s degree in Physics and Science for Engineering from the University of Strasbourg in 2010. Subsequently, he pursued a Master’s degree in Medical Physics at the University of Grenoble, graduating in 2012. Dr. Detappe furthered his expertise with a Medical Physics residency at CEA Saclay in 2012-2013. His academic journey culminated in a PhD in Biophysics from the University of Lyon in 2017, followed by obtaining French authorization to supervise research from the University of Strasbourg in 2020. 🎓🔬

 

AWARDS

Dr. Alexandre Detappe’s groundbreaking contributions in biophysics and cancer research have garnered him numerous prestigious awards and fellowships. In 2021, he was honored with the Guy Ourisson Award by Cercle Gutenberg/University of Strasbourg, recognizing his outstanding achievements. His exceptional work also earned him the Brigitte Mérand Award from the Force Hémato Foundation in 2020 and the Brian D Novis Research Grant Award from the International Myeloma Foundation. Notably, his research excellence was acknowledged with the ASH Abstract Achievement Award in 2018 and the Marie Curie Award for the Best PhD in Radiation Oncology in 2016. Dr. Detappe’s accolades highlight his significant contributions to advancing medical science. 🏆🔬

 

RESEARCH FOCUS

Dr. Alexandre Detappe’s research spans various facets of cancer therapy and imaging, with a particular focus on leveraging nanotechnology for improved treatment outcomes. He explores innovative strategies such as nanoparticle-mediated drug delivery, image-guided radiation therapy, and molecular targeting. His work aims to enhance treatment efficacy while minimizing side effects, particularly in cancers like multiple myeloma and breast cancer. Through a multidisciplinary approach integrating biophysics, molecular biology, and nanomedicine, Dr. Detappe pioneers advancements in precision medicine, striving to make cancer therapies more effective and accessible. 🧬⚗️🔬

 

PUBLICATION TOP NOTES

Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies.

Influence of pneumatic transportation on the stability of monoclonal antibodies.

Site-Selective Protein Conjugation by a Multicomponent Ugi Reaction.

An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering

Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma.

Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.

A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.

Optimal Physicochemical Properties of Antibody–Nanoparticle Conjugates for Improved Tumor Targeting

Anti‐BCMA Immuno‐NanoPET Radiotracers for Improved Detection of Multiple Myeloma

Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation

Zalike Keskin Erdogan | Tissue Engineering | Best Researcher Award

Published on by Global Academic Awards

Dr. Zalike Keskin Erdogan | Tissue Engineering | Best Researcher Award

Dr. Zalike Keskin Erdogan, Imperial College London, United Kingdom

Dr. Zalike Keskin Erdogan, PhD, is a Postdoctoral Research Associate at Imperial College London, specializing in microfluidic encapsulation of biosensors and tissue engineering. With a background in biomedical engineering and extensive experience in cell culture and biomaterials, she has led projects, authored numerous publications, and presented at international conferences. Dr. Keskin Erdogan’s research focuses on developing innovative solutions for regenerative medicine, particularly in neural tissue engineering and wound healing. She is an active member of several professional societies and has received prestigious awards for her contributions. 🧪🔬📚

 

Publication Profile:

Google scholar

Education:

Dr. Zalike Keskin Erdogan’s academic journey reflects her dedication to advancing biomedical sciences. She earned her PhD in Medical Sciences from University College London, UK, specializing in neural tissue engineering with hydrogel-phosphate glass fiber constructs. During her doctoral studies, she published extensively, presented at international conferences, and received prestigious scholarships and travel funds. Her MSc in Biomaterials and Tissue Engineering from Ege University, Turkey, showcased her prowess in bioartificial skin development, while her BEng in Bioengineering laid the foundation for her mechanical characterization expertise. Dr. Keskin Erdogan’s academic achievements exemplify her commitment to pushing the boundaries of bioengineering. 🎓🔬📚

 

Professional Experience:

Dr. Zalike Keskin Erdogan, PhD, is currently a Postdoctoral Research Associate at the Department of Chemical Engineering, Imperial College London, UK. Her expertise lies in the innovative field of microfluidic encapsulation, where she leads a project focusing on whole cell biosensors for co-culturing with mammalian cells and utilizing flow cytometry. With prior roles as a Research Assistant at Izmir Economy University and a Graduate Assistant at Ege University, Turkey, Dr. Keskin Erdogan has honed her skills in biomedical and bioengineering research. She actively mentors students, contributes to academic publications, and explores novel applications of hydrogel-based biomaterials. 🧪🔬📝

 

Research Focus:

Dr. Zalike Keskin Erdogan’s research focus encompasses a wide range of areas within biomedical engineering and biomaterials science. Her work spans the development and characterization of novel biomaterials for various applications, including skin tissue engineering, drug delivery systems for glaucoma treatment, and scaffold design for bone defect treatment. Additionally, she investigates the utilization of bioprinted tissue constructs for neural injury repair and explores the implications of different substrates on cellular response, such as astrocytes. Dr. Keskin Erdogan’s multidisciplinary research endeavors aim to address critical challenges in regenerative medicine and tissue engineering, ultimately contributing to advancements in healthcare. 🧬🔬🩺

Publication Top Notes:

Novel keratin modified bacterial cellulose nanocomposite production and characterization for skin tissue engineering

Recent advances in drug delivery systems for glaucoma treatment

SIS/aligned fibre scaffold designed to meet layered oesophageal tissue complexity and properties

Crosslinking of poly (vinyl alcohol) nanofibres with polycarboxylic acids: Biocompatibility with human skin keratinocyte cells

A review of functionalised bacterial cellulose for targeted biomedical fields

Poly-ε-caprolactone/fibrin-alginate scaffold: a new pro-angiogenic composite biomaterial for the treatment of bone defects

Utilization of GelMA with phosphate glass fibers for glial cell alignment

Modular orthopaedic tissue engineering with implantable microcarriers and canine adipose-derived mesenchymal stromal cells

Therapeutic Application of an Ag-Nanoparticle-PNIPAAm-Modified Eggshell Membrane Construct for Dermal Regeneration and Reconstruction

Inclusion of calcium phosphate does not further improve in vitro and in vivo osteogenesis in a novel, highly biocompatible, mechanically stable and 3D printable polymer